RANKL and OPG are expressed in malignant plasma cells of patients with multiple myeloma
Havah Schneider(The Alfred Hospital), Vittorio Grill(St Vincents Institute of Medical Research), Mu Cheng(The Alfred Hospital), Matthew T. Gillespie(Hudson Institute of Medical Research), M. Cole‐Sinclair(The Alfred Hospital)
Cited by 2
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536
Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
|Endocrinology|1998|452
Activated T Lymphocytes Support Osteoclast Formation in Vitro
|Biochemical and Biophysical Research Communications|1999|425